ACEI and ARB Lower the Incidence of End-Stage Renal Disease among Patients with Diabetic Nephropathy: A Meta-analysis

OBJECTIVE: This study explores the effects of Angiotensin-Converting Enzyme Inhibitors (ACEI) or Angiotensin Receptor Blockers (ARB) on the incidence of end-stage renal disease (ESRD) in diabetic nephropathy (DN) patients. METHODS: Literatures were searched in PubMed, Embase, Medline, CENTRAL, and C...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Xiaojuan, Li, Dayun, Tang, Qiufeng, Chen, Yueyao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173958/
https://www.ncbi.nlm.nih.gov/pubmed/35685896
http://dx.doi.org/10.1155/2022/6962654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173958/
https://www.ncbi.nlm.nih.gov/pubmed/35685896
http://dx.doi.org/10.1155/2022/6962654

Ejemplares similares